United States· US:24562-001_4d02df76-e1f1-4ae6-be11-dc75d2b37c65

Fludeoxyglucose

A fludeoxyglucose (18f) product containing fludeoxyglucose f-18, registered in United States by Biomedical Research Foundation of Northwest Louisiana. The same ATC class is registered in 11 of our 19 countries.

ATC V09IX04Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFludeoxyglucoseATCV09IX04REGISTER NO.US:24562-001_4d02df76…PACKS LISTED1CHECKEDJune 3, 2026

Where it is registered

Fludeoxyglucose (18f) is registered in 11 of 19 countries.

Countries holding a registration under ATC V09IX04 (fludeoxyglucose (18f)), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose

Fludeoxyglucose (18f) · ATC V09IX04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Fludeoxyglucose F-18
Manufacturer
Biomedical Research Foundation of Northwest Louisiana
Country
United States (US)
ATC code
V09IX04
ATC class
Fludeoxyglucose (18F)
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    2456200130
    30 mL in 1 VIAL, GLASS (24562-001-30)

Regulatory notes

UNII (FDA substance ID)
0Z5B2CJX4D
FLUDEOXYGLUCOSE F-18
RxCUI 1362737
Orange Book
A203710
AP
DailyMed SPL labels
1 version tracked

Interactions

46 interactions on record for fludeoxyglucose (18f).

Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fludeoxyglucose (18f) · interactions on record

46 records

  • 46 moderate

Most severe, free to view

  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Liquid paraffinA06AA01moderate
  • BisacodylA06AB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fludeoxyglucose (18f) in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fludeoxyglucose (18f) products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · [18f] Fludeoxyglucose Biont, [18f] Fludeoxyglucose Curium
  • Belgium · (18f) Fludeoxyglucose Curium, Fludeoxyglucose (18f) Rtm
  • Bulgaria · [18f] Фдг Биокосмос, Bulrad 18f-Fdg
  • Cyprus · [18f] Fdg, Fludeoxyglucose (18f) Ge Healthcare
  • Czechia · [18f]fdg-Fr, 2-[18f]-Fdg Radiomedic
  • Germany · [18f]-Fdg-Fzk Zag Zyklotron, [18f]fdg
  • Denmark · Flucore, Fludeoxyglucose (F-18)
  • Estonia · [18f]fdg-Fr Life Radiopharma, Fludeomap
  • Spain · Barnascan, Fludesoxiglucosa (18f) Curium
  • Finland · Fludeomap
  • France · Efdege, Fludesoxyglucose (18f) Curium
  • United Kingdom (Northern Ireland) · Ertracer, Fludeoxyglucose (18f) Alliance Medical Radiopharmacy
  • Greece · [18f] Fdg Βιοκοσμοσ, Fludeoxyglucose (18f) Ge Healthcare
  • Croatia · Efdege, Fdg-Rmc
  • Hungary · Fdg Kedoi, Gluco-Pet
  • Ireland · Ertracer
  • Italy · Efdege, Fluodeossiglucosio (18f ) Curium
  • Lithuania · Fludeomap, Fludeoxyglucose (18f)
  • Luxembourg · (18f) Fludeoxyglucose Curium, [18f]fdg-Fr
  • Latvia · [18f]fdg-Fr, Fludeomap
  • Malta · Fludeoxyglucose (18f) Curium
  • Netherlands · [18f]fdg, 18f-Fdg Hoboken
  • Norway · Fludeomap, Fludeoxyglucose (18f) Ge Healthcare
  • Poland · Fdg Pozyton Centrum Onkologii Im. Prof. Franciszka Łukaszczyka W Bydgoszczy, Fdgtomosil
  • Portugal · Fludeoxiglucose (18f) Curium, Gluscan
  • Romania · Fid-F, Fludeoxiglucoză (18f) Monrol
  • Sweden · Flucorpus, Fludeomap
  • Slovenia · [18f]fludeoksiglukoza Curium, Efdege
  • Slovakia · [18f]fdg-Fr Alliance Medical Rp Berlin Gmbh, 18-Fd-Glukoza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e64ab355-d358-411e-aeff-d6d43c8e3397
GET /v1/drugs/e64ab355-d358-411e-aeff-d6d43c8e3397?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "0Z5B2CJX4D",
    "rxcui": "1362737",
    "inchikey": "AOYNUTHNTBLRMT-MXWOLSILSA-N",
    "display_name": "FLUDEOXYGLUCOSE F-18",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "3535020f-26c3-40b8-bdb5-1aaa1857ba57": {
      "match": "brand_token",
      "title": "FLUDEOXYGLUCOSE F-18 INJECTION [PHARMALOGIC SOUTH CAROLINA, LLC]",
      "spl_version": "15",
      "published_date": "2026-05-25"
    }
  },
  "productid": "24562-001_4d02df76-e1f1-4ae6-be11-dc75d2b37c65",
  "productndc": "24562-001",
  "dosage_form": "INJECTION, SOLUTION",
  "orange_book": {
    "appl_no": "203710",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "20-300mCi/ML",
        "product_no": "001",
        "approval_date": "May 1, 2015"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "FLUDEOXYGLUCOSE F-18",
  "proprietary_name": "Fludeoxyglucose",
  "active_ingred_unit": "mCi/mL",
  "application_number": "ANDA203710",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Fludeoxyglucose F-18",
  "start_marketing_date": "20150514",
  "active_numerator_strength": "300"
}

See everything about fludeoxyglucose (18f).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.